{
    "2019-02-12": [
        [
            {
                "time": "2019-02-12",
                "original_text": "J&J's nasal spray for depression wins FDA panel backing",
                "features": {
                    "keywords": [
                        "J&J",
                        "nasal spray",
                        "depression",
                        "FDA",
                        "approval"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-02-12",
                "original_text": "U.S. FDA panel recommends approval of Johnson & Johnson's depression drug",
                "features": {
                    "keywords": [
                        "FDA",
                        "approval",
                        "Johnson & Johnson",
                        "depression drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-02-12",
                "original_text": "Dow Analyst Moves: JNJ",
                "features": {
                    "keywords": [
                        "Dow",
                        "analyst moves",
                        "JNJ"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-12",
                "original_text": "SEC Allows Rejection of Mandatory Shareholder Arbitration",
                "features": {
                    "keywords": [
                        "SEC",
                        "rejection",
                        "mandatory shareholder arbitration"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "regulation",
                        "corporate governance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-02-12",
                "original_text": "ARWRâ€™s 2019 Goals Include Data From Several Studies, Initiation of Ph2 ARO-AAT",
                "features": {
                    "keywords": [
                        "ARWR",
                        "goals",
                        "data",
                        "studies",
                        "Ph2",
                        "ARO-AAT"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-02-12",
                "original_text": "Health Care Sector Update for 02/12/2019: KMDA, GILD, MDGS, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "health care sector",
                        "update",
                        "KMDA",
                        "GILD",
                        "MDGS",
                        "JNJ",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-12",
                "original_text": "The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares",
                "features": {
                    "keywords": [
                        "biotech pulse",
                        "NASH",
                        "disappointment",
                        "Gilead",
                        "Xeris",
                        "shares"
                    ],
                    "sentiment_score": -0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-12",
                "original_text": "SEC Rejects Proposal for Mandatory Shareholder Arbitration",
                "features": {
                    "keywords": [
                        "SEC",
                        "rejects",
                        "proposal",
                        "mandatory shareholder arbitration"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "regulation",
                        "corporate governance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}